All Products & Services Research Use Only (RUO) CE-Marked Assays View all products

Wall Charts

Hematologic Malignancy Testing Algorithm

Clonality Testing Strategy

AML Patients:

If you are an acute myeloid leukemia patient
who is either contemplating participation in,
or currently participating in a clinical trial
that involves a drug that requires FLT3
testing, make sure you verify with your
physician that your FLT3 test is being
performed by LabPMM. Learn more.

Are you willing and BCR/ABL?
The world's leading clinical laboratories are participating in our international BCR/ABL RT-QPCR standardization & harmonization project, "Are you willing and BCR/ABL?" Learn more on how you can participate.

Personalized Medicine & IVS
Invivoscribe is a leading provider of clinically-validated CE-marked in vitro diagnostic products. Through our subsidiary, LabPMM, we provide worldwide access to state of the art personalized molecular testing to physicians and cancer centers, enabling doctors to determine optimal treatment for each individual patient.

Research & Biotechnology
Development & Partnering
Companion Diagnostics

Upcoming Meetings and Conferences

September 24-26, 2010
ESH-ICMLF 12th International Conference - CML, Washington, D.C. USA

November 17-20, 2010
AMP 2010 Annual Meeting, San Jose, CA USA

December 4-7, 2010
52nd ASH Annual Meeting, Orlando, FL USA

View all Events

We are growing...

Invivoscribe will expand into additional facilities by year-end 2010. The move will double our existing space in the U.S. and provide more room for GMP manufacturing, shipping, and other business units.

View all Press Releases